PRA Health Sciences, Inc.
PRAH
PRAH was delisted on the 30th of June, 2021.
329 hedge funds and large institutions have $6.49B invested in PRA Health Sciences, Inc. in 2019 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 134 increasing their positions, 120 reducing their positions, and 56 closing their positions.
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
12% more repeat investments, than reductions
Existing positions increased: 134 | Existing positions reduced: 120
1% less call options, than puts
Call options by funds: $35.1M | Put options by funds: $35.5M
7% less funds holding
Funds holding: 354 → 329 (-25)
11% less capital invested
Capital invested by funds: $7.26B → $6.49B (-$776M)
34% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 56
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$379M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
+$61.8M |
| 3 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$60.4M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$46M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$27.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$195M |
| 2 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$98.9M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$73.4M |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
-$54.4M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$52.9M |
PRAH Hedge Fund Activity: Q2 2019 in Review
329 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in PRA Health Sciences, Inc. (PRAH) for Q2 2019, worth a combined $6.49B — down 11% from $7.26B a quarter earlier.
Sellers outnumbered buyers: 56 funds closed out of PRAH and 37 opened new positions — a net loss of 19 holders — while 120 trimmed existing stakes and 134 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $379M. The largest seller was Fidelity Investments, cutting an estimated $195M.
- 329 institutional investors held PRA Health Sciences, Inc. (PRAH) as of Q2 2019, down from 354 in Q1 2019.
- Funds reported $6.49B of PRA Health Sciences, Inc. stock for Q2 2019, down 11% quarter-over-quarter.
- 37 funds opened new PRA Health Sciences, Inc. positions in Q2 2019 and 56 closed out, a net change of -19 holders.
- The largest PRA Health Sciences, Inc. buyer in Q2 2019 was T. Rowe Price Associates, an estimated $379M added.
- The largest PRA Health Sciences, Inc. seller in Q2 2019 was Fidelity Investments, an estimated $195M sold.
Based on aggregated 13F filings for Q2 2019.